Literature DB >> 20014064

Myopathy causing camptocormia in idiopathic Parkinson's disease: a multidisciplinary approach.

Simone Spuler1, Henriette Krug, Christine Klein, Isabel Chaure Medialdea, Wibke Jakob, Georg Ebersbach, Doreen Gruber, Karl-Titus Hoffmann, Thomas Trottenberg, Andreas Kupsch.   

Abstract

Extreme forward flexion of the spine, named camptocormia (CC), and head drop syndrome (HD) may be among the most disabling symptoms in Parkinson's disease (PD). This study aims to eludicate the etiology of PD-associated CC and HD via a multidisciplinary approach (clinical examination, electromyography, MRI, genetic analysis, muscle morphology) centering on the histology of the paraspinal muscles. We studied 17 patients with the clinical diagnosis of PD and CC or head drop syndrome and six controls. We performed muscle biopsies of paraspinal muscles and deep neck extensor muscles. Mean age at onset of postural abnormality was 66 years and mean latency between onset of parkinsonian symptoms to first signs of CC or head drop was 7 years. The electromyogram of paraspinal muscles was abnormal in 13-14 patients. Histopathology revealed chronic myopathic changes in 14 of 17 biopsies, consisting of abnormal variation in fiber size, increase in internal nuclei, and increase in connective tissue, myofibrillar disarray and similarities to protein surplus myopathies. Interestingly, heterozygous variants in the Parkin gene were found in 2 of 9 investigated patients. We conclude that CC and HD in PD are predominantly myopathic. Aberrant protein aggregation may link PD and CC. (c) 2009 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20014064     DOI: 10.1002/mds.22913

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  20 in total

1.  Clinical subtypes of anterocollis in parkinsonian syndromes.

Authors:  Gonzalo J Revuelta; Michael Benatar; Alan Freeman; Thomas Wichmann; H A Jinnah; Mahlon R DeLong; Stewart A Factor
Journal:  J Neurol Sci       Date:  2011-11-30       Impact factor: 3.181

Review 2.  Camptocormia in Parkinson's disease: definition, epidemiology, pathogenesis and treatment modalities.

Authors:  Prachaya Srivanitchapoom; Mark Hallett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-20       Impact factor: 10.154

3.  MRI of lumbar trunk muscles in patients with Parkinson's disease and camptocormia.

Authors:  N G Margraf; A Rohr; O Granert; J Hampel; A Drews; G Deuschl
Journal:  J Neurol       Date:  2015-05-01       Impact factor: 4.849

4.  [Causes of camptocormia].

Authors:  F X Glocker; U G Berninger
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

5.  Camptocormia phenotype of FSHD: a clinical and MRI study on six patients.

Authors:  Berit Jordan; Katharina Eger; Sabrina Koesling; Stephan Zierz
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

Review 6.  Surgical treatment of spinal disorders in Parkinson's disease.

Authors:  Fabio Galbusera; Tito Bassani; Elena Stucovitz; Carlotta Martini; Maryem-Fama Ismael Aguirre; Pedro L Berjano; C Lamartina
Journal:  Eur Spine J       Date:  2018-02-03       Impact factor: 3.134

7.  Diagnostic criteria for camptocormia in Parkinson's disease: A consensus-based proposal.

Authors:  Alfonso Fasano; Christian Geroin; Alfredo Berardelli; Bastiaan R Bloem; Alberto J Espay; Mark Hallett; Anthony E Lang; Michele Tinazzi
Journal:  Parkinsonism Relat Disord       Date:  2018-05-08       Impact factor: 4.891

Review 8.  Postural instability in patients with Parkinson's disease. Epidemiology, pathophysiology and management.

Authors:  Samuel D Kim; Natalie E Allen; Colleen G Canning; Victor S C Fung
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

9.  An ¹⁸F-FDG PET study of cervical muscle in parkinsonian anterocollis.

Authors:  Gonzalo J Revuelta; Jaime Montilla; Michael Benatar; Alan Freeman; Thomas Wichmann; Hyder A Jinnah; Mahlon R Delong; Stewart A Factor
Journal:  J Neurol Sci       Date:  2014-03-18       Impact factor: 3.181

Review 10.  Therapy-resistant symptoms in Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Roberta Biundo; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2015-09-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.